Coronavirus – Disease, Medical Sciences Involved & Preventive Measures

What is Molnupiravir?

Note4Students

From UPSC perspective, the following things are important :

Prelims level : Molnupiravir

Mains level : Vaccine for covid

A new drug called Molnupiravir has been shown to stop the transmission of SARS-CoV-2 in 24 hours.

Must read:

What is mRNA vaccine?

Molnupiravir

  • Molnupiravir is an experimental antiviral drug which is orally active and was developed for the treatment of influenza.
  • It is a drug of the synthetic nucleoside derivative N4-hydroxycytidine, and exerts its antiviral action through introduction of copying errors during viral RNA replication.
  • Molnupiravir is being developed by the biotechnology firm Ridgeback Biotherapeutics in collaboration with pharmaceutical firm Merck.
  • The research team repurposed MK-4482/EIDD-2801 against SARS-CoV-2 and tested it on ferrets.
  • This is the first demonstration of an orally available drug to rapidly block SARS-CoV-2 transmission and it can be a game-changer.
Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments